Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4841636

Brc1cnc2[nH]c(-c3ccc(OCCN4CCOCC4)cc3)nc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.53
TBK1 Q9UHD2 6/20 0.51
ADORA3 P0DMS8 1/20 0.49
ADORA2A P29274 1/20 0.49
ADORA2B P29275 1/20 0.49
ADORA1 P30542 1/20 0.49
ULK1 O75385 1/20 0.48
RUNX1 Q01196 2/20 0.47
DHODH Q02127 1/20 0.47
IKBKE Q14164 1/20 0.47
CHEK2 O96017 1/20 0.45
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4840513 0.94 ACHE (0.46) ACHETBK1ADORA3ADORA2AADORA2B
Trifluoroacetic Acid SCHEMBL4842116 0.92 CHEK2 (0.53) ACHETBK1ADORA3ADORA2AADORA2B
SCHEMBL4834923 0.91 ACHE (0.62) ACHETBK1ADORA3ADORA2AADORA2B
Trifluoroacetic Acid SCHEMBL4841456 0.91 CHEK2 (0.45) ACHETBK1ADORA3ADORA2AADORA2B
Trifluoroacetic Acid SCHEMBL4843197 0.91 TBK1 (0.51) ACHETBK1ADORA3ADORA2AADORA2B
Trifluoroacetic Acid SCHEMBL4840800 0.90 CHEK2 (0.45) ACHETBK1ADORA3ADORA2AADORA2B
Trifluoroacetic Acid SCHEMBL4842301 0.89 DRD2 (0.54) ACHETBK1CHEK2
Trifluoroacetic Acid SCHEMBL4846269 0.89 CHEK2 (0.44) ACHETBK1IKBKECHEK2
Trifluoroacetic Acid SCHEMBL4834798 0.88 CYP4F2 (0.49) ACHETBK1IKBKECHEK2
Trifluoroacetic Acid SCHEMBL5258099 0.88 TBK1 (0.44) ACHETBK1IKBKECHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 ACHE 1390/4885TBK1 1029/4885ADORA3 694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.